Global Nanomedicine Therapeutics Market Research Report: Forecast (2023-2028)

By Application (Drug Delivery, Regenerative Medicine, Vaccines, Active Implants, Others), By Indication (Oncology, Infectious Disease, Cardiology, Neurological Disease, Others), By...... Region (North America, South America, Europe, Asia-Pacific, Middle East & Africa), By Company (Johnson & Johnson Ltd, Bristol-Myers Squibb Company, Ipsen Pharma, GlaxoSmithKline plc, Arrowhead Pharmaceuticals, Inc., Nanospectra Biosciences, Cristal Therapeutics, MagArray, Inc. , BlueWillow Biologics, MagForce NT GmbH, Acrotech Biopharma LLC, Recordati S.p.A., Ratiopharm GmbH, Alnylam Pharmaceuticals., Clene Nanomedicine) Read more

  • Healthcare
  • Jun 2023
  • 194
  • PDF, Excel, PPT

Market Definition

Nanomedicine is an area of science that employs particles at the nanoscale range to be used as a treatment in case of various ailments. The major benefit of nanomaterials involves their ability to deliver drug molecules to their specific site of action & facilitate the controlled release of drugs. In this, most nanoparticles ranging from 1nm to 100nm are used, as they possess properties that are not available in bulk materials. The most significant of them include their higher reactivity & ability to pass through membranes, which play a key role in improving therapeutic activities.

Market Insights & Analysis: Global Nanomedicine Therapeutics Market (2023-28)

The Global Nanomedicine Therapeutics Market is projected to grow at a CAGR of around 12.5% during the forecast period, i.e., 2023-28. The major factors supporting the growth of the market have been their vast application in the treatment of cancer. They have shown promising results in targeted cancer therapies during the historical years. They improve the drug accumulation & pharmacokinetics of drug molecules, which has been resulting in better patient outcomes. Also, they have been found to supplement the effectiveness of other cancer therapies like radiotherapy, photothermal therapy, etc.

Further, there has been a spike in the number of cancer cases globally. Consequently, the ever-increasing number of cancer cases has been boosting the need for cancer nanomedicines over the past few years. As per International Agency for Research on Cancer (IARC), new cancer cases are expected to grow to around 27.5 million by 2040, primarily due to the rising prevalence of risk factors, such as smoking, unhealthy diet, physical inactivity, etc. Henceforth, this would further create the need for better therapeutic products for treatment in the upcoming years.

Report Coverage Details
Study Period Historical Data: 2018-21
Base Year: 2022
Forecast Period: 2023-28
CAGR (2023-2028) 12.5%
Regions Covered North America: US, Canada, Mexico
Europe: Germany, The UK, France, Spain, Italy, Rest of Europe
Asia-Pacific: China, India, Japan, South Korea, Australia, Rest of Asia-Pacific
South America: Brazil, Rest of South America
Middle East & Africa: UAE, Saudi Arabia, South Africa, Rest of MEA
Key Companies Profiled Johnson & Johnson Ltd, Bristol-Myers Squibb Company, Ipsen Pharma, GlaxoSmithKline plc, Arrowhead Pharmaceuticals, Inc., Nanospectra Biosciences, Cristal Therapeutics, MagArray, Inc. , BlueWillow Biologics, MagForce NT GmbH, Acrotech Biopharma LLC, Recordati S.p.A., Ratiopharm GmbH, Alnylam Pharmaceuticals., Clene Nanomedicine
Unit Denominations USD Million/Billion

 

Moreover, nanomaterials contain novel physicochemical properties, which have been used to develop several neurological & cardiovascular drugs. It was attributed to their smaller size, which enhances their membrane penetration & improves intra- & intercellular interactions of the drugs. In drug development, nanomaterials have been mostly used for coating purposes, which have been found to facilitate the delivery of drugs inside the human body. The most popularly used structure was the liposomes, which have been highly commercialized as Nanoscale Drug Delivery Systems (NDDS) during 2018-2022. Moreover, considering the highly effective nature of liposomal nanoparticles as drug carriers, several companies have launched their drug candidates in the market. For instance:

  • In 2020, Insmed Netherlands B.V., receive EU approval for its liposomal nanoparticle drug, i.e., Arikayce liposomal, which can be used for Respiratory Tract Infections.

In addition, in light of the enhanced adoption of liposomal nanomedicines, companies like Sierra Oncology, Inc., SynCore Biotechnology Co., Ltd., etc., have been researching their candidates, which are under clinical trial. Therefore, a long list of nanomedicines in the trial pipeline would create a great opportunity for Global Nanomedicine Therapeutics Market expansion in the forthcoming years.

Global Nanomedicine Therapeutics Market Research Report (2023-2028) - Table of Contents

 

  1. Market Segmentation
  2. Introduction
    1. Product Definition
    2. Research Process
    3. Assumptions
  3. Executive Summary
  4. Global Nanomedicine Therapeutics Market: Background & Overview
    1. Advantage of Nanoparticles as Nanocarriers
    2. Natural Compounds Used in Nanomedicine
    3. Recent Advancements to Explore New Areas of Applications
    4. Nanomedicine Development Timeline
  5. Global Nanomedicine Therapeutics Market Start-up Ecosystem
    1. Entrepreneurial Activity
    2. Year-on-Year Funding Received
    3. Funding Received by Top Companies
    4. Key Investors Active in the Market
    5. Series Wise Funding Received
      1. Seed Funding
      2. Angel Investing
      3. Venture Capitalist (VC) Funding
      4. Others
  6. Global Nanomedicine Therapeutics Market Trends & Developments
  7. Global Nanomedicine Therapeutics Market Dynamics
    1. Growth Drivers
    2. Challenges
  8. Global Nanomedicine Therapeutics Market Regulations, Policies & Standards
    1. Guidelines for Treatments
    2. Guidelines for Manufacturing and Marketing of Nanomedicine
  9. Global Nanomedicine Therapeutics Market Hotspots & Opportunities
  10. Global Nanomedicine Therapeutics Market Clinical Trial Analysis
  11. Global Nanomedicine Therapeutics Market Patent Analysis
  12. Global Nanomedicine Therapeutics Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Application
        1. Drug Delivery- Market Size & Forecast 2018-2028, USD Million
        2. Regenerative Medicine- Market Size & Forecast 2018-2028, USD Million
        3. Vaccines - Market Size & Forecast 2018-2028, USD Million
        4. Active Implants- Market Size & Forecast 2018-2028, USD Million
        5. Others (Controlled Drug Release, Combination therapy, etc.) - Market Size & Forecast 2018-2028, USD Million
      2. By Indication
        1. Oncology- Market Size & Forecast 2018-2028, USD Million
        2. Infectious Disease- Market Size & Forecast 2018-2028, USD Million
        3. Cardiology- Market Size & Forecast 2018-2028, USD Million
        4. Neurological Disease- Market Size & Forecast 2018-2028, USD Million
        5. Others (Orthopaedics, Urology, etc.) - Market Size & Forecast 2018-2028, USD Million
      3. By Region
        1. North America
        2. South America
        3. Europe
        4. Middle East & Africa
        5. Asia-Pacific
      4. By Company
        1. Competition Characteristics
        2. Revenue Shares & Analysis
  13. North America Nanomedicine Therapeutics Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Application- Market Size & Forecast 2018-2028, USD Million
      2. By Indication- Market Size & Forecast 2018-2028, USD Million
      3. By Country
        1. The US
        2. Canada
        3. Mexico
    3. The US Nanomedicine Therapeutics Market Outlook, 2018-2028F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Application- Market Size & Forecast 2018-2028, USD Million
        2. By Indication- Market Size & Forecast 2018-2028, USD Million
    4. Canada Nanomedicine Therapeutics Market Outlook, 2018-2028F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Application- Market Size & Forecast 2018-2028, USD Million
        2. By Indication- Market Size & Forecast 2018-2028, USD Million
    5. Mexico Nanomedicine Therapeutics Market Outlook, 2018-2028F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Application- Market Size & Forecast 2018-2028, USD Million
        2. By Indication- Market Size & Forecast 2018-2028, USD Million
  14. South America Nanomedicine Therapeutics Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Application- Market Size & Forecast 2018-2028, USD Million
      2. By Indication- Market Size & Forecast 2018-2028, USD Million
      3. By Country
        1. Brazil
        2. Rest of Latin America
    3. Brazil Nanomedicine Therapeutics Market Outlook, 2018-2028F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Application- Market Size & Forecast 2018-2028, USD Million
        2. By Indication- Market Size & Forecast 2018-2028, USD Million
  15. Europe Nanomedicine Therapeutics Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Application- Market Size & Forecast 2018-2028, USD Million
      2. By Indication- Market Size & Forecast 2018-2028, USD Million
      3. By Country
        1. Germany
        2. The UK
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
    3. Germany Nanomedicine Therapeutics Market Outlook, 2018-2028F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Application- Market Size & Forecast 2018-2028, USD Million
        2. By Indication- Market Size & Forecast 2018-2028, USD Million
    4. The UK Nanomedicine Therapeutics Market Outlook, 2018-2028F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Application- Market Size & Forecast 2018-2028, USD Million
        2. By Indication- Market Size & Forecast 2018-2028, USD Million
    5. France Nanomedicine Therapeutics Market Outlook, 2018-2028F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Application - Market Size & Forecast 2018-2028, USD Million
        2. By Indication- Market Size & Forecast 2018-2028, USD Million
    6. Italy Nanomedicine Therapeutics Market Outlook, 2018-2028F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Application- Market Size & Forecast 2018-2028, USD Million
        2. By Indication- Market Size & Forecast 2018-2028, USD Million
    7. Spain Nanomedicine Therapeutics Market Outlook, 2018-2028F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Application- Market Size & Forecast 2018-2028, USD Million
        2. By Indication- Market Size & Forecast 2018-2028, USD Million
  16. The Middle East & Africa Nanomedicine Therapeutics Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Application- Market Size & Forecast 2018-2028, USD Million
      2. By Indication- Market Size & Forecast 2018-2028, USD Million
      3. By Country
        1. The UAE
        2. Saudi Arabia
        3. South Africa
        4. Rest of MEA
    3. The UAE Nanomedicine Therapeutics Market Outlook, 2018-2028F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Application- Market Size & Forecast 2018-2028, USD Million
        2. By Indication- Market Size & Forecast 2018-2028, USD Million
    4. Saudi Arabia Nanomedicine Therapeutics Market Outlook, 2018-2028F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Application- Market Size & Forecast 2018-2028, USD Million
        2. By Indication- Market Size & Forecast 2018-2028, USD Million
    5. South Africa Nanomedicine Therapeutics Market Outlook, 2018-2028F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Application- Market Size & Forecast 2018-2028, USD Million
        2. By Indication- Market Size & Forecast 2018-2028, USD Million
  17. Asia-Pacific Nanomedicine Therapeutics Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Application- Market Size & Forecast 2018-2028, USD Million
      2. By Indication- Market Size & Forecast 2018-2028, USD Million
      3. By Country
        1. China
        2. India
        3. Japan
        4. South Korea
        5. Australia
        6. Rest of Asia-Pacific
    3. China Nanomedicine Therapeutics Market Outlook, 2018-2028F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Application- Market Size & Forecast 2018-2028, USD Million
        2. By Indication- Market Size & Forecast 2018-2028, USD Million
    4. India Nanomedicine Therapeutics Market Outlook, 2018-2028F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Application - Market Size & Forecast 2018-2028, USD Million
        2. By Indication- Market Size & Forecast 2018-2028, USD Million
    5. Japan Nanomedicine Therapeutics Market Outlook, 2018-2028F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Application - Market Size & Forecast 2018-2028, USD Million
        2. By Indication- Market Size & Forecast 2018-2028, USD Million
    6. South Korea Nanomedicine Therapeutics Market Outlook, 2018-2028F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Application - Market Size & Forecast 2018-2028, USD Million
        2. By Indication- Market Size & Forecast 2018-2028, USD Million
    7. Australia Nanomedicine Therapeutics Market Outlook, 2018-2028F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Application- Market Size & Forecast 2018-2028, USD Million
        2. By Indication- Market Size & Forecast 2018-2028, USD Million
  18. Global Nanomedicine Therapeutics Market Key Strategic Imperatives for Success & Growth
  19. Competition Outlook
    1. Company Profiles
      1. Johnson & Johnson Ltd
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      2. Bristol-Myers Squibb Company
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      3. Ipsen Pharma
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      4. GlaxoSmithKline plc
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      5. Arrowhead Pharmaceuticals, Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      6. Nanospectra Biosciences
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      7. Cristal Therapeutics
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      8. MagArray, Inc. 
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      9. BlueWillow Biologics
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      10. MagForce NT GmbH
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      11. Acrotech Biopharma LLC
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      12. Recordati S.p.A.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      13. Ratiopharm GmbH
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      14. Alnylam Pharmaceuticals
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      15. Clene Nanomedicine
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
  20. Disclaimer


MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

Data Trangulation

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

FILL THE FORM TO INQUIRE BEFORE BUYING THIS REPORT

Your data is 100% confidential & secure

By submitting, you agree to our Terms and Privacy Policy .

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Buy Now
Related Reports
Talk to our Consultant Talk to our Consultant
Customization Offered
  • Cross-segment Market Size & Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report
  • Go To Market Strategy
  • Region Specific Market Dynamics & Share
  • Import Export & Production Analysis
Request Customization Request Customization